% | $
Quotes you view appear here for quick access.

Geron Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ajthedrifter ajthedrifter Dec 21, 2011 3:41 PM Flag

    Something to consider

    Trial enrollment is a an arduous process. Candidates must be screened and qualified and depending on how the treatment is manufactured requires time. Prerequisites must be met as well.

    I believe IMUC has over 21 sites enrolling for their phase 2 GBM trial and have been enrolling at a rapid pace.

    I like GERN I think its been way oversold.

2.63+0.09(+3.54%)Feb 12 4:00 PMEST